The use of imaging to identify immunocompromised children requiring biopsy for invasive fungal rhinosinusitis.
Julie H HarreldRobert A KaufmanGuolian KangGabriela MaronWilliam MitchellJerome W ThompsonAshok SrinivasanPublished in: Pediatric blood & cancer (2020)
In symptomatic, severely immunocompromised children, the presence or absence of fungal-specific imaging findings may effectively rule in or rule out early IFRS, potentially sparing some patients the risks associated with biopsy.